3 Other information

3.1 Scope and how this guideline was developed

NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.

How this guideline was developed

NICE commissioned the National Clinical Guideline Centre to develop this guideline. The Centre established a Guideline Development Group (see section 4), which reviewed the evidence and developed the recommendations.

The methods and processes for developing NICE clinical guidelines are described in the guidelines manual.

3.2 Related NICE guidance

Details are correct at the time of publication of the guideline (August 2015). Further information is available on the NICE website.



Under development

NICE is developing the following guidance:

  • Type 2 diabetes in adults (update). NICE guideline. Publication expected October 2015.

  • Type 1 diabetes: Integrated sensor‑augmented pump therapy systems for managing blood glucose levels (The MiniMed Paradigm Veo System and the Vibe and G4 PLATINUM CGM system). NICE diagnostics guidance. Publication expected January 2016.

  • Buccal insulin for managing type 1 diabetes. NICE technology appraisal guidance. Publication date to be confirmed.

  • National Institute for Health and Care Excellence (NICE)